Terms: = Endocrine gland cancer AND HOXA11, HOX1, 3207, ENSG00000005073, HOX1I, P31270
17 results:
1. nc-RNA-mediated high expression of CDK6 correlates with poor prognosis and immune infiltration in pancreatic cancer.
Zhao YX; Xu BW; Wang FQ; Jiang FY; Xu JW; Yu DX
Cancer Med; 2023 Feb; 12(4):5110-5123. PubMed ID: 36457244
[TBL] [Abstract] [Full Text] [Related]
2. Long non-coding RNA hoxa11-AS knockout inhibits proliferation and overcomes drug resistance in ovarian cancer.
Chen Y; Cui Z; Wu Q; Wang H; Xia H; Sun Y
Bioengineered; 2022 May; 13(5):13893-13905. PubMed ID: 35706412
[TBL] [Abstract] [Full Text] [Related]
3. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.
Xu Z; Wang L; Dai S; Chen M; Li F; Sun J; Luo F
JAMA Netw Open; 2021 Sep; 4(9):e2124750. PubMed ID: 34554237
[TBL] [Abstract] [Full Text] [Related]
4. Utility of subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance category in ultrasound-guided thyroid fine-needle aspiration in a large referral cancer center.
Gan Q; Edeiken BS; Chen MM; Grubbs EG; Busaidy NL; Zafereo M; Perrier ND; Gule-Monroe MD; Krishnamurthy S
J Am Soc Cytopathol; 2019; 8(6):309-316. PubMed ID: 31526696
[TBL] [Abstract] [Full Text] [Related]
5. The impact of diabetes mellitus on clinical outcomes following chemotherapy for the patients with pancreatic cancer: a meta-analysis.
Ma J; Wang J; Ge L; Long B; Zhang J
Acta Diabetol; 2019 Oct; 56(10):1103-1111. PubMed ID: 31069497
[TBL] [Abstract] [Full Text] [Related]
6. Long Non-coding RNA
Yim GW; Kim HJ; Kim LK; Kim SW; Kim S; Nam EJ; Kim YT
Cancer Res Treat; 2017 Jul; 49(3):656-668. PubMed ID: 27737536
[TBL] [Abstract] [Full Text] [Related]
7. A functional variant in hoxa11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer.
Richards EJ; Permuth-Wey J; Li Y; Chen YA; Coppola D; Reid BM; Lin HY; Teer JK; Berchuck A; Birrer MJ; Lawrenson K; Monteiro AN; Schildkraut JM; Goode EL; Gayther SA; Sellers TA; Cheng JQ
Oncotarget; 2015 Oct; 6(33):34745-57. PubMed ID: 26430965
[TBL] [Abstract] [Full Text] [Related]
8. The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migration.
Cheng Y; Jutooru I; Chadalapaka G; Corton JC; Safe S
Oncotarget; 2015 May; 6(13):10840-52. PubMed ID: 25912306
[TBL] [Abstract] [Full Text] [Related]
9. The novel, small-molecule DNA methylation inhibitor SGI-110 as an ovarian cancer chemosensitizer.
Fang F; Munck J; Tang J; Taverna P; Wang Y; Miller DF; Pilrose J; Choy G; Azab M; Pawelczak KS; VanderVere-Carozza P; Wagner M; Lyons J; Matei D; Turchi JJ; Nephew KP
Clin Cancer Res; 2014 Dec; 20(24):6504-16. PubMed ID: 25316809
[TBL] [Abstract] [Full Text] [Related]
10. Epigenetic resensitization to platinum in ovarian cancer.
Matei D; Fang F; Shen C; Schilder J; Arnold A; Zeng Y; Berry WA; Huang T; Nephew KP
Cancer Res; 2012 May; 72(9):2197-205. PubMed ID: 22549947
[TBL] [Abstract] [Full Text] [Related]
11. A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer.
Fang F; Balch C; Schilder J; Breen T; Zhang S; Shen C; Li L; Kulesavage C; Snyder AJ; Nephew KP; Matei DE
Cancer; 2010 Sep; 116(17):4043-53. PubMed ID: 20564122
[TBL] [Abstract] [Full Text] [Related]
12. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution.
Theoharis CG; Schofield KM; Hammers L; Udelsman R; Chhieng DC
Thyroid; 2009 Nov; 19(11):1215-23. PubMed ID: 19888859
[TBL] [Abstract] [Full Text] [Related]
13. HOXA methylation in normal endometrium from premenopausal women is associated with the presence of ovarian cancer: a proof of principle study.
Widschwendter M; Apostolidou S; Jones AA; Fourkala EO; Arora R; Pearce CL; Frasco MA; Ayhan A; Zikan M; Cibula D; Iyibozkurt CA; Yavuz E; Hauser-Kronberger C; Dubeau L; Menon U; Jacobs IJ
Int J Cancer; 2009 Nov; 125(9):2214-8. PubMed ID: 19621443
[TBL] [Abstract] [Full Text] [Related]
14. hoxa11 DNA methylation--a novel prognostic biomarker in ovarian cancer.
Fiegl H; Windbichler G; Mueller-Holzner E; Goebel G; Lechner M; Jacobs IJ; Widschwendter M
Int J Cancer; 2008 Aug; 123(3):725-9. PubMed ID: 18478570
[TBL] [Abstract] [Full Text] [Related]
15. A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly.
Mercado M; Borges F; Bouterfa H; Chang TC; Chervin A; Farrall AJ; Patocs A; Petersenn S; Podoba J; Safari M; Wardlaw J;
Clin Endocrinol (Oxf); 2007 Jun; 66(6):859-68. PubMed ID: 17465997
[TBL] [Abstract] [Full Text] [Related]
16. Early morbidity of endoscopic ultrasound: 13 years' experience at a referral center.
Bournet B; Migueres I; Delacroix M; Vigouroux D; Bornet JL; Escourrou J; Buscail L
Endoscopy; 2006 Apr; 38(4):349-54. PubMed ID: 16680633
[TBL] [Abstract] [Full Text] [Related]
17. Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract.
Cheng W; Liu J; Yoshida H; Rosen D; Naora H
Nat Med; 2005 May; 11(5):531-7. PubMed ID: 15821746
[TBL] [Abstract] [Full Text] [Related]
